Systemic treatment in atopic dermatitis after 2018: from experienced‐based treatment to evidence‐based treatment?
Systemic treatment in atopic dermatitis after 2018: from experienced‐based treatment to evidence‐based treatment?
复制标题
2018年后特应性皮炎的系统治疗：从经验治疗到循证治疗？
DOI：
10.1111/bjd.19227
复制
发表时间：
2020
影响因子：
10.3
通讯作者：
M. D. de Bruin‐Weller
中科院分区：
文献类型：
--
作者：
M. D. de Bruin‐Weller
特点、临床评价及发病机制新观点。中国皮肤科杂志2018；78:1-12。[3]李建军，李建军，李建军，等。斑秃与健康相关的生活质量：一项系统回顾和荟萃分析。中华皮肤科杂志2016；175:561 - 71。[4]李建军，李建军，李建军，等。脱发伴斑秃、雄激素性脱发和休止期脱发患者的HrQoL：人格特质和心理社会焦虑的作用中国生物医学工程学报（英文版）；33:608-11。[5] Titeca G, Goudetsidis L， Francq B等。“斑秃和雄激素发生的社会心理负担”：一项在13个欧洲国家皮肤科门诊患者中的横断面多中心研究。中国生物医学工程学报（英文版）；34:406-11。[6]张丽娟，张丽娟，张丽娟，等。斑秃症状影响量表的研究进展。中华皮肤科杂志，2013；16: S51-2。[7]李建军，李建军，李建军，等。斑秃患者的生活质量：一份疾病特异性问卷。中国生物医学工程学报，2013；27日:e276 - 81。[8]王晓东，王晓东，王晓东，等。斑秃患者生活质量评价指标的研究进展。journal of dermatology 2012；22:531-6。[9]王建军，王建军，王建军，等。斑秃头皮毛发评估PRO测量的发展。[J]中华皮肤科杂志2020；183:1065 - 72。[10]王建军，王建军，王建军，等。斑秃研究者全球评估量表：一种评估临床试验中临床意义成功的方法。[J]中华皮肤科杂志2020；183:702-9。
characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol 2018; 78:1–12. 3 Rencz F, Gulacsi L, Pentek M et al. Alopecia areata and healthrelated quality of life: a systematic review and meta-analysis. Br J Dermatol 2016; 175:561–71. 4 Russo PM, Fino E, Mancini C et al. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. J Eur Acad Dermatol Venereol 2019; 33:608–11. 5 Titeca G, Goudetsidis L, Francq B et al. ‘The psychosocial burden of alopecia areata and androgenetica’: a cross-sectional multicentre study among dermatological out-patients in 13 European countries. J Eur Acad Dermatol Venereol 2020; 34:406–11. 6 Mendoza TR, Osei JS, Shi Q, Duvic M. Development of the Alopecia Areata Symptom Impact Scale. J Investig Dermatol Symp Proc 2013; 16:S51–2. 7 Fabbrocini G, Panariello L, De Vita V et al. Quality of life in alopecia areata: a disease-specific questionnaire. J Eur Acad Dermatol Venereol 2013; 27:e276–81. 8 Endo Y, Miyachi Y, Arakawa A. Development of a disease-specific instrument to measure quality of life in patients with alopecia areata. Eur J Dermatol 2012; 22:531–6. 9 Wyrwich KW, Kitchen H, Knight S et al. Development of the Scalp Hair Assessment PRO measure for alopecia areata. Br J Dermatol 2020; 183:1065–72. 10 Wyrwich KW, Kitchen H, Knight S et al. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials. Br J Dermatol 2020; 183:702–9.
DOI：
10.1111/jdv.13599
发表时间：
2016-05-01
影响因子：
9.2
作者：
Wollenberg, A.;Oranje, A.;Darsow, U.
通讯作者：
Darsow, U.